You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 18 No. 6, June 1968 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Neonatal Hyperbilirubinemia and Kernicterus

Experimental Support for Treatment by Exposure to Visible Light

Ivan Diamond, MD; Rudi Schmid, MD

Arch Neurol. 1968;18(6):699-702.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CREMER et al1 noted that in infants with neonatal icterus exposure to sunlight resulted in a prompt reduction of the serum bilirubin level; this was subsequently confirmed by other investigatiors.2 Broughton et al3 and Lucey et al4 explored the possibility of applying this observation to the treatment of uncomplicated neonatal hyperbilirubinemia.

Bilirubin is a lipid-soluble molecule which readily crosses the blood-brain barrier in either direction.5 In the plasma, bilirubin is tightly bound to albumin which greatly limits the access of the pigment to the central nervous system (CNS).5,6 Illumination of bilirubin in vitro leads to progressive decomposition of the pigment, eventually resulting in loss of its yellow color and its characteristic absorption spectrum in the visible range.7-9 Although the exact chemical structure of these decomposition products is unclear, they are known to be more polar and hence, more water-soluble than bilirubin.8-10 . . . [Full Text PDF of this Article]


Author Affiliations

Chicago; San Francisco

From the Department of Medicine (Neurology), University of Chicago, Chicago (Dr. Diamond). and the Department of Medicine, University of California, San Francisco (Dr. Schmid). Dr. Diamond is now at Harvard Medical School, Boston.


Footnotes

Submitted for publication Jan 19, 1968; accepted Jan 30.

Reprint requests to Department of Biological Chemistry, Harvard Medical School, Boston 02115 (Dr. Diamond).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1968 American Medical Association. All Rights Reserved.